Laboratorios Farmacéuticos Rovi has expanded the presence of its enoxaparin in Europe, after launching a rival to Sanofi’s Lovenox under its own name in Spain and introducing its Crusia version in France via a partnership with Biogaran.
Rovi has launched in Spain – “one of the main enoxaparin markets in Europe” – under the brand name ‘Enoxaparina...





